What changed from existing technology?
This study looked at how doctors diagnose and treat children with a heart condition called Brugada syndrome, finding that about half met the criteria for the condition, but more research is needed to understand how to best manage it.
The study highlights the challenges in diagnosing Brugada syndrome in children and provides insights into the clinical outcomes based on established diagnostic criteria.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 2
icability of current diagnostic criteria for pediatric patients with suspected BrS in the German multicenter study COGIA and to assess clinical outcome. Metho
Abstract ↗OpenAlex author affiliations: World of Medicine (Germany)
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Near commercialization
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
The study suggests that current diagnostic criteria for Brugada syndrome may be applicable in pediatric patients, but further research is needed to refine management strategies.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.
Evidence and sources
View paper and author affiliations
Open original researchBrugada Syndrome in the Pediatric Population: Diagnostic Challenges and Clinical Outcome—Results of the German Multicenter Study COGIAJournal of Cardiovascular Electrophysiology · Published 2026-08-30 ↗Author institutions and listed legal entities are separated; only verified exchange and ticker data is linked.